WebMD2y
Keeping Track of Medication for Schizophrenia
This can be tricky. And the effects of schizophrenia can make it even harder to remember to keep track of your meds. Make a master list of what medicines you take. Keep one at home, and one to ...
verywellhealth9d
Cobenfy: The First New Schizophrenia Drug in Decades
The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...
FDA Approves Potentially Groundbreaking Schizophrenia Drug
On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel ...
F.D.A. Approves the First New Schizophrenia Drug in Decades
Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.
FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades
The twice-daily pill, Cobenfy, is a badly needed new treatment option for the nearly 3 million adults in the U.S. living with ...
Managed Healthcare Executive23y
FDA Approves the Oral Medication KarXT for Schizophrenia
KarXT — now with the brand name Cobenfy— is expected to be available in October with a list price of about $22,500 annually.
FDA approves a novel drug for schizophrenia, a potential ‘game changer’
The approval comes less than a year Bristol Myers Squibb paid $14 billion to acquire the developer of the drug, Karuna ...
New schizophrenia drug ‘could change the lives of millions of people’
A groundbreaking new drug to treat schizophrenia called Cobenfy, owned by pharmaceutical firm Bristol Myers Squibb, has been ...
Yahoo Finance13d
Bristol Myers schizophrenia drug, the first of its kind, approved by FDA
Recommended Reading Psychiatry drugs finally have ... than a dozen antipsychotics for schizophrenia, and many have ...
WVTF12d
A new kind of drug for schizophrenia promises fewer side effects
A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...
pharmaphorum2d
Boehringer licenses Sosei schizophrenia drugs in €755m deal
Boehringer Ingelheim has taken an option on a family of compounds with potential as therapies for schizophrenia ... of all marketed drugs, and Boehringer adds to a growing list of partners that ...
btimesonline12d
FDA Approves Bristol Myers Squibb’s Cobenfy, First Novel Schizophrenia Drug in 70 Years
Bristol Myers Squibb received U.S. Food and Drug Administration (FDA) approval on Thursday for its groundbreaking ...